bf/NASDAQ:AUPH_icon.png

COM:AURINIAPHARMA

Aurinia Pharmaceuticals Inc.

  • Stock

USD

Last Close

8.77

22/11 21:00

Market Cap

786.60M

Beta: -

Volume Today

1.56M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
278K
-
235K
15.47%
173K
26.38%
420K
142.77%
463K
10.24%
318K
31.32%
50.12M
15,660.38%
45.60M
9.00%
134.03M
193.89%
175.51M
30.95%
cost of revenue
37K
-
12K
67.57%
4K
66.67%
1K
75%
41.38M
4,138,100%
52.87M
27.75%
50.33M
4.80%
1.09M
97.83%
5.66M
419.16%
14.15M
149.79%
gross profit
241K
-
223K
7.47%
169K
24.22%
419K
147.93%
-40.92M
9,865.87%
-52.55M
28.42%
-209K
99.60%
44.51M
21,398.56%
128.37M
188.37%
161.37M
25.71%
selling and marketing expenses
general and administrative expenses
6.89M
-
6.26M
9.10%
6.97M
11.29%
12.10M
73.54%
13.67M
13.05%
22.15M
62.02%
95.98M
333.25%
171.44M
78.61%
196.37M
14.54%
195.04M
0.68%
selling general and administrative expenses
6.89M
-
6.26M
9.10%
6.97M
11.29%
12.10M
73.54%
13.67M
13.05%
22.15M
62.02%
95.98M
333.25%
171.44M
78.61%
196.37M
14.54%
195.04M
0.68%
research and development expenses
9.11M
-
15.98M
75.40%
14.53M
9.06%
33.93M
133.45%
41.38M
21.96%
52.87M
27.75%
50.33M
4.80%
51.14M
1.61%
44.99M
12.03%
49.64M
10.34%
other expenses
-4.21M
-
-848K
79.84%
-337K
60.26%
-1.63M
383.68%
195K
111.96%
2.06M
958.97%
1.55M
25.04%
1.29M
16.73%
2.67M
107.29%
-1.52M
157.00%
8.38M
650.16%
cost and expenses
17.56M
-
23.82M
35.62%
22.99M
3.48%
47.48M
106.56%
56.62M
19.24%
76.57M
35.23%
147.60M
92.77%
226.34M
53.35%
245.50M
8.47%
258.82M
5.43%
operating expenses
4.98M
-
17.52M
251.97%
23.80M
35.84%
22.98M
3.44%
47.48M
106.60%
56.62M
19.25%
76.57M
35.23%
147.60M
92.77%
225.25M
52.61%
239.84M
6.48%
244.68M
2.02%
interest expense
30K
-
50K
66.67%
27K
46%
702K
2,500%
2.23M
218.23%
39K
98.25%
5.12M
-
2.77M
45.78%
ebitda
-15.70M
-
-26.95M
71.67%
-20.83M
22.71%
-21.68M
4.11%
-44.64M
105.87%
-80.99M
81.44%
-96.19M
18.77%
-178.64M
85.71%
-111.47M
37.60%
-71.67M
35.71%
operating income
-17.28M
-
-23.58M
36.44%
-22.81M
3.25%
-47.06M
106.29%
-56.16M
19.33%
-82.54M
46.98%
-104.29M
26.35%
-180.74M
73.30%
-111.47M
38.32%
-83.31M
25.26%
depreciation and amortization
1.52M
-
1.56M
2.43%
1.48M
5.07%
1.46M
1.56%
1.56M
7.49%
1.55M
1.09%
8.10M
423.13%
2.10M
74.09%
2.71M
28.98%
11.65M
330.41%
total other income expenses net
600K
-
4.92M
720.50%
-508K
110.32%
-23.73M
4,571.06%
-7.89M
66.75%
-41.16M
421.78%
1.52M
103.68%
529K
65.11%
5.12M
867.49%
5.84M
14.17%
income before tax
-16.65M
-
-18.61M
11.77%
-23.30M
25.19%
-70.79M
203.89%
-64.05M
9.53%
-123.70M
93.14%
-102.77M
16.92%
-180.21M
75.34%
-106.35M
40.98%
-77.47M
27.16%
income tax expense
30K
-
-4.97M
16,676.67%
481K
109.67%
23.92M
4,873.80%
73K
99.69%
144K
97.26%
-94K
165.28%
760K
908.51%
1.83M
140.53%
551K
69.86%
net income
-2.55M
-
-16.65M
553.83%
-18.61M
11.77%
-23.30M
25.19%
-70.79M
203.89%
-64.12M
9.42%
-123.85M
93.15%
-102.68M
17.09%
-180.97M
76.24%
-108.18M
40.22%
-78.02M
27.88%
weighted average shs out
6.34M
-
29.16M
359.62%
32.15M
10.28%
35.28M
9.74%
76.95M
118.08%
84.78M
10.18%
93.02M
9.72%
118.47M
27.36%
129.37M
9.20%
141.91M
9.70%
143.24M
0.93%
weighted average shs out dil
6.34M
-
29.16M
359.62%
32.15M
10.28%
35.28M
9.74%
76.95M
118.08%
84.78M
10.18%
93.02M
9.72%
118.47M
27.36%
129.37M
9.20%
141.91M
9.70%
143.24M
0.93%
eps
-0.40
-
-0.57
42.50%
-0.58
1.75%
-0.66
13.79%
-0.92
39.39%
-0.76
17.39%
-1.33
75.00%
-0.87
34.59%
-1.40
60.92%
-0.76
45.71%
-0.54
28.95%
epsdiluted
-0.40
-
-0.57
42.50%
-0.58
1.75%
-0.66
13.79%
-0.92
39.39%
-0.76
17.39%
-1.33
75.00%
-0.87
34.59%
-1.40
60.92%
-0.76
45.71%
-0.54
28.95%

All numbers in USD (except ratios and percentages)